Using mRNA technology to arm the immune system against HIV
Development of mRNA vaccines has opened a brand-new tool for researchers to use in the...
Learn MoreDecember 12, 2022
Everyone ages differently: Cardiovascular disease and HIV
The CTN’s HIV and Aging Cohort Study aims to understand how HIV can affect the development of heart disease, and what can be done to address it
Learn More
Taking Pride in our sexual health and wellbeing
The CTN 334: Sex Now/Test Now 2022 team is hitting the streets at Pride festivals across Canada to better understand the health and wellbeing of the GBT2Q community
Learn More
Age, altruism, or a long-term view: Why do people living with HIV get the COVID-19 vaccine?
Understanding COVID-19 vaccine confidence in people living with HIV in Canada
Learn More
Collaborating to close the gap in women’s health care and research
To mark International Women’s Day, we sat down with the CTN 335 investigators to learn about how their research could improve healthy aging for women living with HIV
Learn More
CTN study tests new drug for the first time in people living with HIV
The drug works against CMV, a common virus that may be a main cause of inflammation and health problems in people living with HIV
Learn More
Improving anal cancer screening among men living with HIV
Ahead of World Cancer Day, we spoke with Dr. Troy Grennan about anal cancer screening among gbMSM living with HIV, a population disproportionately affected by the condition
Learn More
Let’s Talk: Addressing mental health in the HIV community
In recognition of Bell Let’s Talk Day, we look at what steps can be taken to improve mental health and wellbeing among people affected by HIV
Learn More
ENGAGing men in HIV prevention and care
CTN 300: The Engage Study is investigating the use of PrEP among urban Canadian gay, bisexual, and other men who have sex with men
Learn More